Dr Oluwaseun Adebayo Bamodu, MD, MS, PhD - Department of Hematology & Oncology, Cancer Center, Taipei Medical University - Shuang Ho Hospital - Medical Research Fellow

Dr Oluwaseun Adebayo Bamodu

MD, MS, PhD

Department of Hematology & Oncology, Cancer Center, Taipei Medical University - Shuang Ho Hospital

Medical Research Fellow

New Taipei City, Taipei | Taiwan

Main Specialties: Cardiovascular Disease, Clinical & Laboratory Immunology, Hematology & Oncology, Internal Medicine, Interventional Cardiology, Oncology, Pharmacology, Radiation Oncology, Statistics, Surgery

Additional Specialties: Clinical Medicine (Oncology/Cancer Research)

ORCID logohttps://orcid.org/0000-0001-8229-0408

Dr Oluwaseun Adebayo Bamodu, MD, MS, PhD - Department of Hematology & Oncology, Cancer Center, Taipei Medical University - Shuang Ho Hospital - Medical Research Fellow

Dr Oluwaseun Adebayo Bamodu

MD, MS, PhD

Introduction

Primary Affiliation: Department of Hematology & Oncology, Cancer Center, Taipei Medical University - Shuang Ho Hospital - New Taipei City, Taipei , Taiwan

Specialties:

Additional Specialties:


View Dr Oluwaseun Adebayo Bamodu’s Resume / CV

Education

Sep 2012 - Jun 2016
Taipei Medical University
PhD
Graduate Institute of Clinical Medicine
May 2015 - May 2016
Universita degli Studi di Milano-Bicocca
M.S
Cardiac Surgery, Cardiology & Cardiac Anesthesia
Oct 2007 - Oct 2009
Horbachevsky Ternopil State Medical University
Specialist Certificate
General Surgery
Nov 2000 - Jun 2007
Northern State Medical University
Doctor of Medicine (MD)
International Faculty of General Practitioners

Experience

Sep 2012 - Sep 2016
Postdoctoral Fellow
Medical Research Fellow
Department of Medical Education and Research/ Translational Research Lab., Shuang Ho Hospital
Sep 2012 - Sep 2016
Medical Research Fellow
Medical Research Fellow
Department of Hematology
Sep 2012 - Sep 2012
Research Assistant
Research Assistant
Department of Medical Education and Research/ Translational Research Lab
Oct 2011 - Oct 2011
Senior Medical Officer
Senior Medical Officer
Consultant Medical Clinic and Dialysis Center
Jul 2010 - Aug 2010
Medical Officer
Medical Officer
National Hospital Abuja

Publications

57Publications

447Reads

1Profile Views

44PubMed Central Citations

Ovatodiolide inhibits the oncogenicity and cancer stem cell-like phenotype of glioblastoma cells, as well as potentiate the anticancer effect of temozolomide.

Phytomedicine 2019 Aug 19;61:152840. Epub 2019 Jan 19.

Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Division of Neurosurgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan; Taipei Neuroscience Institute, Taipei Medical University, Taipei, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09447113183062
Publisher Site
http://dx.doi.org/10.1016/j.phymed.2019.152840DOI Listing
August 2019
15 Reads
3.126 Impact Factor

Ovatodiolide suppresses nasopharyngeal cancer by targeting stem cell-like population, inducing apoptosis, inhibiting EMT and dysregulating JAK/STAT signaling pathway.

Phytomedicine 2019 Mar 8;56:269-278. Epub 2018 May 8.

Department of Otolaryngology - Head and Neck Surgery, Shuang Ho Hospital, Taipei Medical University, Taiwan; Department of Otolaryngology, School of Medicine, College of Medicine, Taipei Medical University, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phymed.2018.05.007DOI Listing
March 2019
3 Reads
3.126 Impact Factor

Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.

Clin Exp Metastasis 2019 Feb;36(1):67

Graduate Institute of Clinical Medicine, Taipei Medical University, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10585-018-9949-zDOI Listing
February 2019
2 Reads
3.491 Impact Factor

Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.

Am J Chin Med 2018 24;46(4):891-910. Epub 2018 May 24.

** Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1142/S0192415X18500477DOI Listing
October 2018
26 Reads
2.625 Impact Factor

Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition.

Exp Cell Res 2018 09 5;370(2):444-453. Epub 2018 Jul 5.

Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei City, Taiwan; Department of Hematology and Oncology, Cancer Center, Taipei Medical University-Shuang Ho Hospital, New Taipei City, Taiwan; Department of Medical Research and Education, Taipei Medical University, Shuang Ho Hospital, New Taipei City, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2018.07.008DOI Listing
September 2018
11 Reads
3.250 Impact Factor

Ovatodiolide suppresses yes-associated protein 1-modulated cancer stem cell phenotypes in highly malignant hepatocellular carcinoma and sensitizes cancer cells to chemotherapy in vitro.

Toxicol In Vitro 2018 Sep 24;51:74-82. Epub 2018 Apr 24.

Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Department of Radiation Oncology, Taipei Medical University-Shuang Ho Hospital, New Taipei City, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08872333183013
Publisher Site
http://dx.doi.org/10.1016/j.tiv.2018.04.010DOI Listing
September 2018
36 Reads
2.903 Impact Factor

HDAC inhibitor suppresses proliferation and tumorigenicity of drug-resistant chronic myeloid leukemia stem cells through regulation of hsa-miR-196a targeting BCR/ABL1.

Exp Cell Res 2018 09 12;370(2):519-530. Epub 2018 Jul 12.

Department of Hematology and Oncology, Cancer Center, Taipei Medical University - Shuang Ho Hospital, New Taipei City, Taiwan, ROC; Department of Medical Research & Education, Taipei Medical University - Shuang Ho Hospital, New Taipei City, Taiwan, ROC; Graduate Institute of Clinical Medicine, Taipei Medical University, Taipei City, Taiwan, ROC. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2018.07.017DOI Listing
September 2018
7 Reads
3.250 Impact Factor

Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor.

Clin Epigenetics 2018 08 9;10(1):107. Epub 2018 Aug 9.

Department of Medical Research and Education, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13148-018-0533-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085612PMC
August 2018
6 Reads

Investigation of ovatodiolide, a macrocyclic diterpenoid, as a potential inhibitor of oral cancer stem-like cells properties via the inhibition of the JAK2/STAT3/JARID1B signal circuit.

Phytomedicine 2018 Jul 12;46:93-103. Epub 2018 Apr 12.

Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Department of Hematology and Oncology, Cancer Center, Taipei Medical University - Shuang Ho Hospital, New Taipei City 23561, Taiwan; Department of Medical Research and Education, Taipei Medical University - Shuang Ho Hospital, New Taipei City 23561, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phymed.2018.04.016DOI Listing
July 2018
35 Reads
3.130 Impact Factor

Activation of the monocytic α7 nicotinic acetylcholine receptor modulates oxidative stress and inflammation-associated development of coronary artery spasm via a p38 MAP-kinase signaling-dependent pathway.

Free Radic Biol Med 2018 05 31;120:266-276. Epub 2018 Mar 31.

Department of Medical Research and Education, Taipei Medical University - Shuang Ho Hospital, New Taipei City, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.freeradbiomed.2018.03.050DOI Listing
May 2018
11 Reads
5.740 Impact Factor

Garcinol inhibits cancer stem cell-like phenotype via suppression of the Wnt/β-catenin/STAT3 axis signalling pathway in human non-small cell lung carcinomas.

J Nutr Biochem 2018 04 27;54:140-150. Epub 2017 Dec 27.

Department of Medical Research and Education, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jnutbio.2017.12.008DOI Listing
April 2018
46 Reads
3.794 Impact Factor

Antrodia cinnamomea sensitizes radio-/chemo-therapy of cancer stem-like cells by modulating microRNA expression.

Su YK, Shih PH, Lee WH, Bamodu OA, Wu ATH, Huang CC, Tzeng YM, Hsiao M, Yeh CT, Lin CM, Journal of ethnopharmacology, 2017, 2017

http://europepmc.org/abstract/med/28602756

View Article
July 2017
3 Reads

Implantation of the Jarvik 2000® left ventricular assist device using the miniaturized extracorporeal circulation system - a case report.

Perfusion 2016 Sep 20;31(6):518-20. Epub 2016 Jan 20.

Cardiac Surgery Unit, San Gerardo Hospital, Department of Medicine and Surgery, School of Medicine, University of Milano-Bicocca, Monza, Italy Cardiac Perfusion Unit, San Gerardo Hospital, Monza, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0267659115627692DOI Listing
September 2016
7 Reads
1.083 Impact Factor

Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.

BMC Cancer 2016 Feb 25;16:160. Epub 2016 Feb 25.

Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei City, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-016-2108-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768424PMC
February 2016
29 Reads
17 Citations
3.362 Impact Factor

Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.

Cancer Lett 2015 Nov 13;368(1):36-45. Epub 2015 Jul 13.

Department of Radiation Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan; Department of Medical Research and Education, Taipei Medical University-Shuang Ho Hospital, Taipei, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2015.07.003DOI Listing
November 2015
21 Reads
9 Citations
5.621 Impact Factor

4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype.

Toxicol Appl Pharmacol 2015 Oct 30;288(2):258-68. Epub 2015 Jul 30.

Institute of Biochemical Sciences and Technology, Chaoyang University of Technology, Taichung 41349, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.taap.2015.07.025DOI Listing
October 2015
77 Reads
2 Citations
3.705 Impact Factor

Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicity.

Cancer Lett 2015 Aug 11;364(2):125-34. Epub 2015 May 11.

Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei City, Taiwan; Department of Medical Research & Education, Taipei Medical University-Shuang Ho Hospital, New Taipei City, Taiwan; Tri-Service General Hospital, Neihu District, Taipei City, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2015.05.006DOI Listing
August 2015
13 Reads
7 Citations
5.621 Impact Factor

4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype.

Chang TC, Yeh CT, Adebayo BO, Lin YC, Deng L, Rao YK, Huang CC, Lee WH, Wu AT, Hsiao M, Wu CH, Wang LS, Tzeng YM, Toxicology and applied pharmacology, 2015

http://europepmc.org/abstract/med/26235807

View Article
July 2015
2 Reads

Top co-authors

Chi-Tai Yeh
Chi-Tai Yeh

National Chung Hsing University

18
Oluwaseun Adebayo Bamodu
Oluwaseun Adebayo Bamodu

Graduate Institute of Clinical Medicine

17
Tsu-Yi Chao
Tsu-Yi Chao

Tri-Service General Hospital

9
Kuang-Tai Kuo
Kuang-Tai Kuo

Taipei Veterans General Hospital

7
Yew-min Tzeng
Yew-min Tzeng

Peking University

6
Michael Hsiao
Michael Hsiao

Kaohsiung Veterans General Hospital

6
Wen-Chien Huang
Wen-Chien Huang

Mackay Memorial Hospital

4
Chun-Chih Huang
Chun-Chih Huang

MedStar Health Research Institute

3